​

Anebulo Pharmaceuticals (ANEB) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

ANEB Stock Forecast

Anebulo Pharmaceuticals (ANEB) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $6.00, with a high of $6.00 and a low of $6.00. This represents a 108.33% increase from the last price of $2.88.

$1 $2 $3 $4 $5 $6 High: $6 Avg: $6 Low: $6 Last Closed Price: $2.88

ANEB Stock Rating

Anebulo Pharmaceuticals stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (75.00%), 1 Hold (25.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 1 3 Strong Sell Sell Hold Buy Strong Buy

ANEB Price Target Upside V Benchmarks

TypeNameUpside
StockAnebulo Pharmaceuticals108.33%
SectorHealthcare Stocks 19.91%
IndustryBiotech Stocks 55.52%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$2.88$2.88$2.88
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 2511---2
Jun, 2511---2
May, 25-1---1
Apr, 25-1---1
Mar, 25-1---1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 18, 2023Boobalan PachaiyappanH.C. Wainwright$6.00$3.2783.49%108.33%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 01, 2024BenchmarkSpeculative BuySpeculative Buyhold
Sep 18, 2023H.C. WainwrightBuyinitialise

Financial Forecast

EPS Forecast

Jun 24 Jun 25 Jun 26 Jun 27 Jun 28
Jun 24Jun 25Jun 26Jun 27Jun 28
Reported$-0.32----
Avg Forecast$-0.42$-0.33$-0.68$-0.55$0.63
High Forecast$-0.42$-0.33$-0.68$-0.30$0.63
Low Forecast$-0.42$-0.33$-0.68$-0.79$0.63
Surprise %-23.81%----

Revenue Forecast

$15M $28M $41M $54M $67M $80M Jun 24 Jun 25 Jun 26 Jun 27 Jun 28
Jun 24Jun 25Jun 26Jun 27Jun 28
Reported-----
Avg Forecast--$16.83M$27.31M$78.75M
High Forecast--$16.83M$27.31M$78.75M
Low Forecast--$16.83M$27.31M$78.75M
Surprise %-----

Net Income Forecast

$-25M $-16M $-7M $2M $11M $20M Jun 24 Jun 25 Jun 26 Jun 27 Jun 28
Jun 24Jun 25Jun 26Jun 27Jun 28
Reported$-8.20M----
Avg Forecast$-10.85M$-8.52M$-17.56M$-19.56M$16.27M
High Forecast$-10.85M$-8.52M$-17.56M$-7.75M$16.27M
Low Forecast$-10.85M$-8.52M$-17.56M$-20.40M$16.27M
Surprise %-24.38%----

ANEB Forecast FAQ

Is Anebulo Pharmaceuticals stock a buy?

Anebulo Pharmaceuticals stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Anebulo Pharmaceuticals is a favorable investment for most analysts.

What is Anebulo Pharmaceuticals's price target?

Anebulo Pharmaceuticals's price target, set by 4 Wall Street analysts, averages $6 over the next 12 months. The price target range spans from $6 at the low end to $6 at the high end, suggesting a potential 108.33% change from the previous closing price of $2.88.

How does Anebulo Pharmaceuticals stock forecast compare to its benchmarks?

Anebulo Pharmaceuticals's stock forecast shows a 108.33% upside, outperforming the average forecast for the healthcare stocks sector (19.91%) and outperforming the biotech stocks industry (55.52%).

What is the breakdown of analyst ratings for Anebulo Pharmaceuticals over the past three months?

  • July 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • June 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Anebulo Pharmaceuticals’s EPS forecast?

Anebulo Pharmaceuticals's average annual EPS forecast for its fiscal year ending in June 2025 is $-0.33, marking a 3.12% increase from the reported $-0.32 in 2024. Estimates for the following years are $-0.68 in 2026, $-0.55 in 2027, and $0.63 in 2028.

What is Anebulo Pharmaceuticals’s revenue forecast?

Anebulo Pharmaceuticals's average annual revenue forecast for its fiscal year ending in June 2025 is $0, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $16.83M, followed by $27.31M for 2027, and $78.75M for 2028.

What is Anebulo Pharmaceuticals’s net income forecast?

Anebulo Pharmaceuticals's net income forecast for the fiscal year ending in June 2025 stands at $-8.521M, representing an 3.90% increase from the reported $-8.202M in 2024. Projections indicate $-17.559M in 2026, $-19.558M in 2027, and $16.27M in 2028.